Internal Medicine, Cardiovascular Disease · Bryn Mawr, PA
NPI
1043428063
Since 2007
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
825 Old Lancaster Rd, Suite 320
Bryn Mawr, PA, 19010
Phone (610) 525-1202
Groups this clinician bills Medicare through
Medicare paid, 2024
$775K
4,865 services
Medicare patients, 2024
1,244
Average age 77
Drug cost, 2024
$1.4M
7,212 prescriptions
Company payments, 2025
$841
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Laura Share Immordino was code 93000 (electrocardiogram), 928 times for 623 patients. In total Laura Share Immordino billed 4,865 services in 47 codes, and Medicare paid $775K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 928 | 623 | $11.02 | $10K |
| 99214 Office E&M - Established | Office | 709 | 526 | $100.45 | $71K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 636 | 159 | $5.13 | $3,263 |
| 93010 Electrocardiogram | Facility | 599 | 497 | $6.47 | $3,874 |
| 99215 Office E&M - Established | Office | 370 | 312 | $127.55 | $47K |
| 93306 Echocardiography (TTE/TEE) | Office | 290 | 282 | $148.29 | $43K |
| 93015 Electrocardiogram | Office | 163 | 161 | $57.71 | $9,406 |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 160 | 158 | $633.08 | $101K |
| 78431 Myocardial Perfusion Scan | Office | 158 | 158 | $1,952.01 | $308K |
| 78434 Myocardial Perfusion Scan | Office | 157 | 157 | $526.51 | $83K |
| 99233 Hospital E&M - Subsequent | Facility | 140 | 71 | $95.09 | $13K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 72 | 71 | $151.02 | $11K |
| 93224 Electrocardiogram | Office | 66 | 62 | $54.26 | $3,581 |
| 99223 Hospital E&M - Initial | Facility | 58 | 53 | $138.66 | $8,042 |
| 93229 Electrocardiogram | Office | 54 | 54 | $667.43 | $36K |
By year: 2022 $633K for 4,299 services; 2023 $623K for 4,461 services; 2024 $775K for 4,865 services.
Medicare prescription drug claims, 2024
In 2024, the drug Laura Share Immordino prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,000 prescriptions and refills. In total Laura Share Immordino wrote 7,212 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,000 | 2,876 | 286 | $22K |
| Metoprolol Succinate Generic | 782 | 2,142 | 213 | $14K |
| Atorvastatin Calcium Generic | 502 | 1,445 | 156 | $7,700 |
| Valsartan Generic | 445 | 1,213 | 121 | $24K |
| Amlodipine Besylate Generic | 444 | 1,228 | 128 | $3,944 |
| Eliquis Apixaban | 356 | 684 | 81 | $393K |
| Ezetimibe Generic | 244 | 724 | 77 | $7,405 |
| Losartan Potassium Generic | 235 | 676 | 72 | $3,532 |
| Lisinopril Generic | 230 | 665 | 62 | $2,770 |
| Furosemide Generic | 214 | 560 | 76 | $1,719 |
| Nifedipine Er Nifedipine | 177 | 430 | 44 | $8,116 |
| Clopidogrel Clopidogrel Bisulfate | 173 | 489 | 53 | $3,533 |
| Carvedilol Generic | 168 | 448 | 52 | $2,362 |
| Hydrochlorothiazide Generic | 154 | 410 | 48 | $538 |
| Labetalol Hcl Generic | 121 | 357 | 32 | $4,369 |
Brand drugs: 757 claims; generic drugs: 6,455 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Laura Share Immordino $841 ($841 in general payments such as food, travel and fees) from 13 companies. The largest payer was Scpharmaceuticals Inc. with $167.
| Company | Payments | Amount |
|---|---|---|
| Scpharmaceuticals Inc. SCPH | 5 | $167 |
| Pfizer Inc. PFE | 9 | $141 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $119 |
| Daiichi Sankyo Inc. 4568.T | 3 | $76.15 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $72.12 |
| Amgen Inc. AMGN | 4 | $57.31 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $49.24 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $48.17 |
| Novo Nordisk Inc NVO | 1 | $27.57 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $26.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.